Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2010
10/21/2010US20100266606 Antibody therapy for highly pathogenic avian influenza virus
10/21/2010US20100266599 Human receptor proteins; related reagents and methods
10/21/2010US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
10/21/2010US20100266592 Therapeutic antennapedia-antibody molecules and methods of use thereof
10/21/2010US20100266579 Treatment of inflammatory diseases
10/21/2010US20100266577 Method of Cancer Treatment with Antagonists of FAS Inhibitors
10/21/2010US20100266575 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING
10/21/2010US20100266574 Oligoribonucleotides and Methods of Use Thereof for Treatment of Fibrotic Conditions and Other Diseases
10/21/2010US20100266569 Prostatic acid phosphatase for the treatment of pain
10/21/2010US20100266548 LPS-Responsive CHS1/Beige-Like Anchor Gene and Therapeutic Applications Thereof
10/21/2010US20100266541 Methods and agents for modulating an immune response
10/21/2010US20100266536 new type of consensus interferon and preparation method thereof
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266507 Luminescent compounds
10/21/2010US20100266493 Agonist antibodies against tshr
10/21/2010CA2758824A1 Plant promoter operable in endosperm and uses thereof
10/21/2010CA2758542A1 Peptides targeting tnf family receptors and antagonizing tnf action, compositions, methods and uses thereof
10/21/2010CA2758005A1 Methods of treating cancers with her3 antisense oligonucleotides
10/20/2010EP2241638A1 Methods for detecting abnormally methylated nucleic acid in heterogeneous biological samples
10/20/2010EP2241635A1 Nucleic acid ligand inhibitors to DNA polymerases
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241572A2 Modulation of survivin expression
10/20/2010EP2240503A2 Optimized probes and primers and method of using same for the detection of herpes simplex virus
10/20/2010EP2021516B1 Nucleic acid primers and probes for detecting human and avian influenza viruses
10/20/2010EP1633890B1 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY AND SPECIFICITY OF FNAi
10/20/2010EP0710280B1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
10/20/2010CN101864412A Methods for synthesis of encoded libraries
10/20/2010CN101863944A Method for extracting chaetoceros densus genomic DNA by microwave method
10/20/2010CN101862345A Modified nucleosides for treatment of viral infections and abnormal cellular proliferation
10/20/2010CN101225106B Short peptide suppressing growth of cancer cell and uses thereof
10/19/2010US7816590 Plants and seeds of corn variety CV338423
10/19/2010US7816588 Inbred sweet corn line R373D
10/19/2010US7816583 Sweet grape tomato
10/19/2010US7816582 Arabinogalactan protein having activity of improving tolerance to heat or moisture stress
10/19/2010US7816512 Short interference RNA duplexes when introduced into mammalian cells in culture perform sequence-specific inhibition of target mRNA without inducing an interferon response; for gene silencing to treat human diseases; double stranded siRNA
10/19/2010US7816511 Screening drugs; prevent gene expression; monitoring cardiovascular disorders
10/19/2010US7816510 Promoter from Zea mays
10/19/2010US7816509 recombinant expression vector carrying the promoter and a heterologous protein encoding base sequence operably linked to the promoter, and a host cell transfected or transformed with the recombinant expression vector; utilized for the mass production of heterologous proteins without the need for inducers
10/19/2010US7816508 DNA active as a modified vaccinia virus Ankara promoter or active as a promoter in vaccinia virus infected cells; expression cassettes having coding sequence codes for therapeutic proteins or peptides, antigens, antigenic epitopes, antisense RNA or ribozymes; vaccines; genetic vectors; avipoxviruses;
10/19/2010US7816506 Methods and constructs for producing transgenic plants and methods of recovering expressed proteins
10/19/2010US7816505 PUFA polyketide synthase systems and uses thereof
10/19/2010US7816504 PUFA polyketide synthase systems and uses thereof
10/19/2010US7816503 increase the intensity of the fluorescent signal after nucleic acid sequencing reactions; a modified fluorescent labelled guanine-containing nucleotides which exhibit enhanced fluorophore intensity
10/19/2010US7816502 Authentication of biologic materials using DNA-DNA hybridization on a solid support
10/19/2010US7816501 Peptide nucleic acids with donor and acceptor moieties for detecting or identifying the presence, absence or quantity of a target sequence of a target molecule such as via fluorescence resonance energy transfer
10/19/2010US7816492 Human G protein-coupled receptors
10/19/2010US7816336 Antisense modulation of hydroxysteroid 11-beta dehydrogenase 1 expression
10/19/2010US7816335 Therapeutic compounds and methods
10/19/2010US7816334 Nucleic acid construct and nucleic acid expression vectors directing expression of a fusion protein consisting of a disease peptide antigen and a first domain of FrC of tetanus toxin; vaccines
10/19/2010US7816333 nucleosides such as 3',5'-di-O-Benzyl-2'-O,4'-C-ethylene-4-N-benzoylcytidine for treatment of pain, psoriasis, inflammatory disorders, infectious skin disease, skin cancer, Lyme disease, influenza virus, cytomegalovirus, herpes virus, herpes simplex virus, papilloma virus, Epstein Barr virus or HIV
10/19/2010US7816315 Method of isolating a nucleic acid using a material containing an amino group and a carboxyl group and positively charged at a first pH and a solid material for nucleic acid isolation used for the method
10/19/2010US7816304 Mass labels
10/19/2010US7816131 Polynucleotide construct having a prostate cancer-specific control sequence including at least 2 of a prostate tissue-specific control sequence; a cancer-specific control sequence; and a two-step transcriptional amplification sequence including a DNA binding domain and an activation domain
10/19/2010US7816129 Production and secretion of proteins of bacterial origin in filamentous fungi
10/19/2010US7816116 Modified creatinine amide hydrolase having improved affinity for substrate, and reagent composition for determination of creatinine
10/19/2010US7816113 Recombinant, heat resistant pullulanase or isoamylase for use in conversion of amylopectin and/or glycogen into high fructose syrups, high maltose syrups, maltodextrins, amylose and/or G4-G6 oligosaccharides for use in food processing
10/19/2010US7816111 Enhanced heat resistant glucose dehydrogenase for coupling to oxido- or reductase enzymes to produce synthetic organic chemicals or precursors
10/19/2010US7816109 Microorganism having the improved gene for hydrogen-generating capability, and process for producing hydrogen using the same
10/19/2010US7816093 using nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners; used as additives and/or removed from foods, beverages and medicinals in order to modify (block) T2R-associated bitter taste
10/19/2010US7816086 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
10/19/2010US7816080 Identifying organisms by detecting intronic nucleic acid or encoded proteins
10/19/2010US7816079 Method of DNA sequencing using cleavable tags
10/19/2010US7816078 Method for identifying biological species
10/19/2010US7815902 Methods and compositions for cancer therapy using a novel adenovirus
10/19/2010US7815896 Type III secretion pathway in Aeromonas salmonicida and uses therefor
10/19/2010CA2495298C Use of antisense oligonucleotides to inhibit the expression of akt-1
10/19/2010CA2429138C Sol-fusin: use of gp64-6his to catalyze membrane fusion
10/19/2010CA2422956C Compositions and methods for detecting human immunodeficiency virus 2 (hiv-2)
10/19/2010CA2407270C Method for indirectly extracting non-cultivable dna organisms and dna obtainable by said method
10/19/2010CA2380395C Conditional-selex
10/19/2010CA2334914C Methods for determining presence of cancer in a sample by determining expression of an ssx gene, peptides derived from said ssx gene and ny-eso-1 gene, and uses thereof
10/19/2010CA2186118C Compacted nucleic acids and their delivery to cells
10/19/2010CA2147499C Prostate-specific membrane antigen
10/14/2010WO2010118264A2 Multiplexed sites for polymer synthesis
10/14/2010WO2010118244A1 Alphavirus Replicon Particles Expressing TRP2
10/14/2010WO2010118235A1 Dna-cell conjugates
10/14/2010WO2010117737A1 Rice transgenic event17053 and methods of use thereof
10/14/2010WO2010117735A1 Transgenic rice event17314 and methods of use thereof
10/14/2010WO2010115261A1 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
10/14/2010WO2010062975A3 Suppressor of ap-1
10/14/2010WO2010062404A3 N-fmoc nucleosides and phosphoramidites, and oligonucleotide synthesis
10/14/2010WO2010048585A3 Oligomeric compounds and methods
10/14/2010US20100263092 improved ability to enzymatically degrade lignocellulosic feedstocks; fermentation
10/14/2010US20100263091 Polypeptides Having Acetylxylan Esterase Activity And Polynucleotides Encoding Same
10/14/2010US20100263088 Promoters From Brassica Napus For Seed Specific Gene Expression
10/14/2010US20100263085 Markers associated with resistance to aphis glycines and methods of use therefor
10/14/2010US20100263066 Inert dna sequences for efficient viral packaging and methods of use
10/14/2010US20100263064 Animal model for chronic obstructive pulmonary disease and cystic fibrosis
10/14/2010US20100261891 Nucleic acid anchoring system comprising covalent linkage of an oligonucleotide to a solid support
10/14/2010US20100261890 Method for the chemical synthesis of oligonucleotides
10/14/2010US20100261881 Marker sequences for rheumatoid arthritis and use thereof
10/14/2010US20100261874 Synthetic genes for plant gums and other hydroxyproline rich glycoproteins
10/14/2010US20100261781 Multivalent aptamer complexes
10/14/2010US20100261778 Tumor Suppressor Killin
10/14/2010US20100261777 Inhibiton of metallo-beta-lactamase by double-stranded dna
10/14/2010US20100261657 Use of a Granulin or a Granulin-Like Compound in the Therapy or Prophylaxis of Chronic Pains
10/14/2010US20100261650 Recombinant fusion proteins to growth hormone and serum albumin
10/14/2010US20100261640 Soluble and membrane anchored forms of lassa virus subunit proteins
10/14/2010US20100261618 Identification of genes implicated in the virulence of streptococcus agalactiae
10/14/2010US20100261291 Nucleic acids specifically binding bioactive ghrelin
1 ... 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 ... 899